Skip to main content
MDGL logo
MDGL
(NASDAQ)
Madrigal Pharmaceuticals, Inc.
$513.47-- (--)
Loading... - Market loading

Madrigal Pharmaceuticals (MDGL) Stock Price & Financial Analysis

Madrigal Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$499.34 - $523.16
52-Week High$615.00
52-Week Low$265.00
Open$518.72
Volume359.53K
Average Volume (3M)284.32K
Market Cap11.48B
Shares Outstanding22.43M
Price to Sales (P/S)11.98
Price to Book (P/B)19.05
EV/EBITDA-40.23
Revenue (TTM)958.40M
Net Income (TTM)-288.28M
Free Cash Flow (TTM)-190.02M
EPS (TTM)$-12.93
Profit Margin-30.08%
Operating Margin-31.31%
Return on Equity (ROE)-47.83%
Debt to Equity0.59
50-Day MA$493.50
200-Day MA$476.07
52-Week Change65.26%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Madrigal Pharmaceuticals

What is the current stock price for MDGL?

As of the latest trading session, MDGL stock trades at $513.47. The 52-week range is $265.00–$615.00, with a day range of $499.34–$523.15.

What is the P/E ratio for MDGL?

The P/E ratio (Price-to-Earnings) for MDGL is shown in the Key Statistics section. This valuation metric helps compare Madrigal Pharmaceuticals, Inc. to industry peers.

Does MDGL pay dividends?

Madrigal Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for MDGL?

Based on 1 analyst, the consensus for MDGL is Hold. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of MDGL?

Madrigal Pharmaceuticals's market capitalization is $11.52B, classifying it as a large-cap company. Madrigal Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.